康梦田,眼科博士,主要从事青少年儿童近视防控和近视发病机制研究。现任北京同仁医院青年临床医疗技术骨干,医管局“近视防控青年职工创新工作室”负责人。长期从事青少年儿童近视防控、 成人屈光手术、近视发病机制的研究工作。中国科协青年托举人才、北京同仁医院拔尖人才,北京同仁医院青年临床医疗技术骨干,优秀教师。北京市医管局近视防控青年职工创新工作室负责人。 获中国教育部自然科学奖一等奖、中国商联会服务业科技创新一等奖。发表学术论文79篇, 以第一或通讯作者在JAMA子刊、IOVS、Nature子刊发表论文13篇,参编《循证眼科学》等专著8部,第一发明人授权专利4项。
Mengtian Kang, MD, PhD in Ophthalmology, specializes in myopia prevention and control in children and adolescents, as well as research on the pathogenesis of myopia. She currently serves as a Young Clinical Medical Technology Backbone at Beijing Tongren Hospital and as Director of the "Youth Innovation Studio for Myopia Prevention and Control" under the Beijing Municipal Administration of Hospitals. She has long been engaged in research on myopia prevention and control in children and adolescents, adult refractive surgery, and the pathogenesis of myopia.She is a recipient of the Young Elite Scientist Sponsorship Program by the China Association for Science and Technology (CAST), a Top-Tier Talent at Beijing Tongren Hospital, a Young Clinical Medical Technology Backbone at Beijing Tongren Hospital, and an Outstanding Teacher. She also serves as Director of the Youth Innovation Studio for Myopia Prevention and Control under the Beijing Municipal Administration of Hospitals.She has received the First Prize of the Natural Science Award from the Ministry of Education of China and the First Prize for Science and Technology Innovation in the Service Industry from the China General Chamber of Commerce. She has published 79 academic papers, including 13 papers as first or corresponding author in journals such as JAMA subsidiary journals, IOVS, and Nature subsidiary journals. She has contributed as a co-editor to 8 monographs including Evidence-Based Ophthalmology, and holds 4 authorized patents as the first inventor.
15
0
0
| 日期 | 时间 | 会场 | Session | 角色 | 讲题 |
|---|---|---|---|---|---|
| 2026-05-30 | 10:29-10:41 | 主会场(一层,N7主会议厅) |
中国近视大会4 规范创新 「全生命周期近视管理」 |
讲者 | 临床剂量红光治疗近视的安全性评价与视网膜辐照度预测模型构建 |